Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
The National Cancer Institute acknowledges that high-dose IVC has demonstrated antitumor activity in preclinical studies and is being investigated in clinical trials
The results obtained were reviewed by the team of authors, who, using the standardized format, extracted relevant information for inclusion in this narrative evidence synthesis
Abstract 518: Erk5 S496 phosphorylation, but not Erk5 kinase or transcriptional activity, is responsible for promoting macrophage inflammation and mitochondrial dysfunction via upregulating novel site of Nrf2 K518 sumoylation
Sports Medicine, 2006
Oncogene (2007) 26(22):327990
US$ 23.47
US$ 20.69
US$ 22.04
